For example, simvastatin suppressed NSCLC proliferation and migration by inducing cell pyroptosis through activating NLRP3 and caspase-1 and promoting the maturation of downstream IL-1β and IL-18 (ref. [86]). This evidence concerns the gene NLRP3 and non-small cell lung carcinoma.